These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10342095)

  • 41. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial.
    Harada T; Momoeda M; Taketani Y; Hoshiai H; Terakawa N
    Fertil Steril; 2008 Nov; 90(5):1583-8. PubMed ID: 18164001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer of the breast and reproductive tract in relation to use of oral contraceptives.
    Schlesselman JJ
    Contraception; 1989 Jul; 40(1):1-38. PubMed ID: 2673658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noncontraceptive benefits of oral contraceptives.
    Mishell DR
    J Reprod Med; 1993 Dec; 38(12 Suppl):1021-9. PubMed ID: 8120859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. When is it safe to switch from oral contraceptives to hormonal replacement therapy?
    Castracane VD; Gimpel T; Goldzieher JW
    Contraception; 1995 Dec; 52(6):371-6. PubMed ID: 8749601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of various oral contraceptive combinations on dysmenorrhea.
    Milsom I; Andersch B
    Gynecol Obstet Invest; 1984; 17(6):284-92. PubMed ID: 6745736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menstrual suppression for adolescents.
    Altshuler AL; Hillard PJ
    Curr Opin Obstet Gynecol; 2014 Oct; 26(5):323-31. PubMed ID: 25110977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beyond birth control. The health benefits of hormonal contraception.
    Geraghty P
    Adv Nurse Pract; 2009 Feb; 17(2):47-8, 50, 52. PubMed ID: 19999425
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral contraceptives. Assessment of benefits.
    Derman R
    J Reprod Med; 1986 Sep; 31(9 Suppl):879-86. PubMed ID: 3772907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone-sparing properties of oral contraceptives.
    DeCherney A
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):15-20. PubMed ID: 8571999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
    Grandi G; Napolitano A; Xholli A; Tirelli A; Di Carlo C; Cagnacci A
    Gynecol Endocrinol; 2015 Oct; 31(10):774-8. PubMed ID: 26291811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Non-contraceptive benefits of contraception].
    Costa FJ
    Sex Planeam Fam; 1995; 8(2):16-8. PubMed ID: 12179257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dysmenorrhea.
    McKenna KA; Fogleman CD
    Am Fam Physician; 2021 Aug; 104(2):164-170. PubMed ID: 34383437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An opinion on the benefits of concomitant oral contraceptive therapy in premenopausal women treated with oral anticoagulants.
    Godin R; Roy G; Douketis J
    Thromb Res; 2018 May; 165():14-17. PubMed ID: 29549777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Noncontraceptive health benefits and risks of steroidal contraception.
    Pasquale SA
    Int J Fertil; 1989; 34 Suppl():85-7. PubMed ID: 2576266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence.
    Jensen JT; Schlaff W; Gordon K
    Fertil Steril; 2018 Jul; 110(1):137-152.e1. PubMed ID: 29937152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Current oral hormonal contraception, a nontraditional look].
    Pavlova E
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():33-4. PubMed ID: 19496451
    [No Abstract]   [Full Text] [Related]  

  • 57. Diagnosis and initial management of dysmenorrhea.
    Osayande AS; Mehulic S
    Am Fam Physician; 2014 Mar; 89(5):341-6. PubMed ID: 24695505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
    Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
    Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
    Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
    Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.